Study uncovers protein that kick-starts milk production after breastfeeding is over

NewsGuard 100/100 Score

Scientists have discovered a protein that kick-starts milk production after breastfeeding is over - something which could provide effective new targets for cancer treatments.

The groundbreaking study from the University of Sheffield uncovered a protein called Rac1, which acts as a critical switch to kick-start milk production in breast cells when lactation has stopped and the breast has already begun returning to its pre-pregnancy state.

Once babies start eating solids, the breasts wind down production of milk and undergo a process of shrinkage to return back to in-activity. The milk producing units are dismantled through cellular suicide to remove the redundant tissue. During intermittent feeding the shrinking breast can remarkably reverse to reinitiate lactation if suckling resumes. Until now it was not known how this process happened.

Dr Nasreen Akhtar and her team from the University of Sheffield's Department of Oncology and Metabolism, investigated mouse mammary glands - which are structurally similar to humans. They discovered that when the Rac1 protein is present cell death occurs with autophagy - a process in which cells start eating their own parts in a desperate bid to survive.

Importantly the study, published in the journal PLOS Biology, revealed that half-dead, half alive cells with autophagy can be brought back to life to recommence milk production, upon suckling but cells without the Rac1 protein cannot.

The discovery could provide new insights into how breast cancer cells acquire resistance to cell death in non-permissive environments.

Rac1 not only causes live breast cells to gobble up their dying neighbors but it's also responsible for cells eating themselves.

Flow of milk caused by suckling is thought to initiate lactation but what happens at the cellular level has baffled scientists for years.

Despite the massive wave of cell death that occurs in the first phase of the end of lactation, if suckling resumes the breast can reverse the process and re-lactate. This is a fail-safe built-in mechanism to prevent the breast from drying up too quickly.

It's particularly important in nature for the survival of mammals, for example if a nursing mammal was separated from her pups for longer than expected whilst foraging, she would still be able feed once reunited.

Remarkably some mammals have a really long reversible phase; for example, the cape fur seal which goes on long offshore foraging trips, for up to 28 days can still re-lactate once suckling resumes ashore."

Dr Nasreen Akhtar, Lead Author, Lecturer in Developmental Cell Biology, University of Sheffield

Dr Akhtar explained why this study could have important implications for targeting cancer cells which are resistant to current therapies.

She added: "The risk of most breast cancer progression is highest in the post-pregnancy years – perhaps caused by an altered activity during the post-weaning remodelling stage.

"The discovery here could expose potential pathways and proteins that cancer cells exploit to survive and grow."

Source:
Journal reference:

Mironov, A., et al. (2023) Rac1 controls cell turnover and reversibility of the involution process in postpartum mammary glands. PLOS Biology. doi.org/10.1371/journal.pbio.3001583.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer